Obesity Facts and Information

Takeda and Amylin to co-develop obesity drugs

Japan’s Takeda Pharmaceutical and U.S. Amylin Pharmaceuticals said on Monday they will co-develop and commercialize drugs to treat obesity, including two Amylin drugs in mid-stage trials. Takeda, Japan’s biggest drug maker and best known for its diabetes drug Actos, will pay Amylin $75 million in a one-time up-front payment under the exclusive worldwide agreement. Amylin, maker of [...]

Continue reading...

Anti-obesity product safe in mid-stage study

NEW YORK (Reuters) – Amylin Pharmaceuticals Inc said on Thursday a mid-stage study of its combination obesity product involving versions of hormones linked to appetite and metabolism yielded positive results. The Phase 2, 28-week study randomized 608 overweight or obese patients to either placebo or various doses of the product, which contains the compounds pramlintide and [...]

Continue reading...

Diabetes Drug Byetta Might Aid Weight Loss in Obese Patients

THURSDAY, June 11 (HealthDay News) — Exenatide (Byetta), a drug normally used to treat diabetes, may also help non-diabetic obese people lose weight when combined with diet and exercise, new research has found. Researchers divided 152 obese men and women (with a body-mass index of greater than 30 and an average weight of 241 pounds) into [...]

Continue reading...